Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
NTII
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.07
N/A
NA
vs NA
Q3.07
N/A
NA
vs NA
Q4.07
N/A
NA
vs NA
Q1.08
N/A
NA
vs NA
Q2.08
N/A
NA
vs NA
Q3.08
N/A
NA
vs NA
Q4.08
N/A
NA
vs NA
Q1.09
N/A
NA
vs NA
Q2.09
N/A
NA
vs NA
Q3.09
N/A
NA
vs NA
Sales Growth
YoY
Current
Estimates
Q2.07
-8%
4M vs 4.3M
Q3.07
-18%
3.9M vs 4.8M
Q4.07
-9%
3.7M vs 4M
Q1.08
-24%
3.7M vs 4.9M
Q2.08
-12%
3.5M vs 4M
Q3.08
-9%
3.6M vs 3.9M
Q4.08
-5%
3.5M vs 3.7M
Q1.09
-18%
3M vs 3.7M
Q2.09
+363%
16.3M vs 3.5M
Q3.09
+69%
6M vs 3.6M
Return on Equity
QoQ
Q4.07
-25%
-0.25
vs 0.05
Q1.08
-22%
-0.22
vs -0.25
Q2.08
-17%
-0.17
vs -0.22
Q3.08
-16%
-0.16
vs -0.17
Q4.08
-94%
-0.94
vs -0.16
Q1.09
-5%
-0.05
vs -0.94
Q2.09
+60%
0.6
vs -0.05
Q3.09
+19%
0.19
vs 0.6
Institutionnal Ownership
Quote Panel
Key Metrics
Relative Strength
NTII
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.
OTC
After-hours NaN$
0.00 (0.00%)
Relative Strenght
Volume Buzz
-72%
Earning Acce
Yes
Dist 52w H.
0%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How NTII compares to sector?